Table 3 Multivariate Cox regression analysis for all post-treatment patients and post-treatment patients with a treatment response of VGPR/CR
PFS ≤18 months (N = 18) | PFS >18 months (N = 18) | Cox regression analysis | |||||
|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | |||||
All patients (N = 36) | Auto-HSCT in 1st line treatment, n | 9 | 2(11.1%) | 7(38.9%) | 0.22 | 0.05-0.97 | 0.046 |
Difference in △CT ≤1.5, n | 17 | 13(72.2%) | 4(22.2%) | 4.89 | 1.73-13.86 | 0.003 | |
PFS ≤18 months (N = 15) | PFS >18 months (N = 18) | ||||||
Patients with VGPR/CR (N = 33) | Auto-HSCT in 1st line treatment, n | 9 | 2(13.3%) | 7(38.9%) | 0.24 | 0.05-1.09 | 0.066 |
Difference in △CT ≤1.5, n | 14 | 10(66.7%) | 4(22.2%) | 4.38 | 1.48-12.99 | 0.008 | |